HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Hojo Selected Research

JTP 2942

1/2000Effect of JTP-2942, a novel thyrotropin-releasing hormone analog, on motor deficits after chronic focal cerebral ischemia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Hojo Research Topics

Disease

6Neoplasms (Cancer)
05/2019 - 11/2005
5Lung Neoplasms (Lung Cancer)
12/2001 - 10/2000
3Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2000 - 01/2000
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2001 - 02/2001
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2001 - 07/2001
2Idiopathic Pulmonary Fibrosis
01/2000 - 01/2000
1Carcinoma (Carcinomatosis)
01/2013
1Hemorrhage
10/2006
1Rupture
10/2006
1Pericardial Effusion
10/2001
1Breast Neoplasms (Breast Cancer)
10/2001
1Chronic Hepatitis (Chronic Active Hepatitis)
08/2001
1Autoimmune Hepatitis
08/2001
1Hepatocellular Carcinoma (Hepatoma)
02/2001
1Leukemia
01/2001
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2001
1Sarcoma (Soft Tissue Sarcoma)
06/2000
1Pulmonary Emphysema
05/2000
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2000
1Lung Injury
01/2000
1Brain Ischemia (Cerebral Ischemia)
01/2000
1Neurologic Manifestations (Neurological Manifestations)
01/2000
1Paresis (Hemiparesis)
01/2000
1Stroke (Strokes)
01/2000

Drug/Important Bio-Agent (IBA)

5Messenger RNA (mRNA)IBA
12/2001 - 05/2000
5Keratin-19 (Keratin 19)IBA
12/2001 - 05/2000
4IsotopesIBA
05/2019 - 12/2015
4AntigensIBA
01/2001 - 01/2000
4CollagenIBA
06/2000 - 01/2000
3Tumor Biomarkers (Tumor Markers)IBA
12/2001 - 10/2000
3antigen CYFRA21.1IBA
12/2001 - 10/2000
2IonsIBA
05/2019 - 11/2018
2EnzymesIBA
11/2001 - 06/2000
2ImmunosorbentsIBA
11/2001 - 06/2000
2AntibodiesIBA
08/2001 - 01/2000
1Aquaporin 5IBA
01/2013
1Small Interfering RNA (siRNA)IBA
01/2013
1Fetal Hemoglobin (Hemoglobin F)IBA
10/2006
1Hemoglobins (Hemoglobin)IBA
10/2006
1Irinotecan (Camptosar)FDA LinkGeneric
11/2005
1Paclitaxel (Taxol)FDA LinkGeneric
11/2005
1Syndecan-1 (Syndecan 1)IBA
11/2001
1oncofetal fibronectinIBA
11/2001
1SyndecansIBA
11/2001
1pirarubicinIBA
10/2001
1Keratins (Keratin)IBA
08/2001
1Carcinoembryonic AntigenIBA
07/2001
1Caspase 3 (Caspase-3)IBA
02/2001
1acarboxyprothrombin (PIVKA)IBA
02/2001
1Prothrombin (Factor II)IBA
02/2001
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2001
1Vitamin KFDA Link
02/2001
1Laminin (Merosin)IBA
06/2000
1GelatinIBA
06/2000
1Fibronectins (Fibronectin)IBA
06/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2000
1Staphylococcal Protein A (Protein A)IBA
05/2000
1Pulmonary Surfactants (Pulmonary Surfactant)IBA
05/2000
1Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA
05/2000
1Cytidine Diphosphate Choline (Citicoline)IBA
01/2000
1Lewis Blood Group AntigensIBA
01/2000
1CarbohydratesIBA
01/2000
1Antigen-Antibody Complex (Immune Complex)IBA
01/2000
1Thyrotropin-Releasing Hormone (Protirelin)FDA Link
01/2000
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2000
1Keratin-8 (Keratin 8)IBA
01/2000
1JTP 2942IBA
01/2000
1prolinamideIBA
01/2000

Therapy/Procedure

5Therapeutics
05/2019 - 10/2001
2Drug Therapy (Chemotherapy)
11/2005 - 10/2001
1Blood Transfusion (Blood Transfusions)
10/2006
1Salpingo-oophorectomy
11/2005
1Hysterectomy
11/2005